Several lines of evidence from experimental animal models of infection have clearly demonstrated the feasibility of a prophylactic and therapeutic vaccine against Helicobacter pylori. However, comparatively few clinical studies have been carried out to evaluate whether the positive results obtained in animals can be reproduced in humans. The preliminary results obtained with single component, mucosally delivered vaccines have shown very limited results thus far. Very good immunogenicity and safety profiles are now being obtained with parenterally delivered, aluminium hydroxide-adjuvanted multicomponent candidate vaccines. For sure, better vaccine formulations, better antigen preparation(s), better adjuvants, and better delivery systems have to be designed and tested for safety and immunogenicity. These studies are also needed for deciphering those aspects of the effector immune responses that correlate with protection against H. pylori infection and disease.

The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? / Ruggiero, P.; Peppoloni, Samuele; Rappuoli, R.; DEL GIUDICE, G.. - In: MICROBES AND INFECTION. - ISSN 1286-4579. - STAMPA. - 5 (8):(2003), pp. 749-756.

The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?

PEPPOLONI, Samuele;
2003

Abstract

Several lines of evidence from experimental animal models of infection have clearly demonstrated the feasibility of a prophylactic and therapeutic vaccine against Helicobacter pylori. However, comparatively few clinical studies have been carried out to evaluate whether the positive results obtained in animals can be reproduced in humans. The preliminary results obtained with single component, mucosally delivered vaccines have shown very limited results thus far. Very good immunogenicity and safety profiles are now being obtained with parenterally delivered, aluminium hydroxide-adjuvanted multicomponent candidate vaccines. For sure, better vaccine formulations, better antigen preparation(s), better adjuvants, and better delivery systems have to be designed and tested for safety and immunogenicity. These studies are also needed for deciphering those aspects of the effector immune responses that correlate with protection against H. pylori infection and disease.
5 (8)
749
756
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? / Ruggiero, P.; Peppoloni, Samuele; Rappuoli, R.; DEL GIUDICE, G.. - In: MICROBES AND INFECTION. - ISSN 1286-4579. - STAMPA. - 5 (8):(2003), pp. 749-756.
Ruggiero, P.; Peppoloni, Samuele; Rappuoli, R.; DEL GIUDICE, G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/457056
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 44
social impact